Clinical-stage biopharmaceutical company Dimerix (ASX: DXB) has today announced that their current Phase 3 drug for kidney disease has been awarded an Innovation Passport and the Innovative Licensing and Access Pathway (ILAP). The designation is awarded by the UK Medicines and Healthcare products Regulatory Agency and is designed to accelerate development of promising medicines to
Read More
As an industry which has long been a vital gateway for organised crime, financial crime regulators appear to finally be catching up in the race with SkyCity Entertainment (ASX: SKC) the latest to have their operations probed by AUSTRAC. The investigation was confirmed this morning by the New Zealand-based company which operates SkyCity Adelaide and
Read More
The slimy sales tactics of prickly real estate agents may be in need of review with Australian property technology company Openn Negotiation set to debut on the ASX on Friday, 11 June. A “proptech” company, Openn uses technology that aims to provide the best possible property sales outcomes for the seller, buyer and real estate
Read More
Industrial and automotive supplies company Stealth Global Holdings (ASX: SGI) has secured some of Australia’s largest companies as new clients as part of a $4.2 million acquisition of Skipper Transport Parts, and its 1,250 customers. At present, Skipper is an operating division within AMCAP, a subsidiary of Eagers Automotive Limited (ASX: APE), Australia’s largest automotive
Read More
Intelligent pain assessment company Painchek (ASX: PCK) is eager to become the new standard of care in aged care settings, today announcing that licensed agreements for their platform’s use now encompass 60% of Australian aged care providers. PainChek’s mobile based pain assessment tool uses AI and facial recognition software to objectively automate and quantify pain
Read More
There is nothing fun about plunging into freezing cold ice water during a cold Melbourne winter. However, each year, bold celebrities participate in the annual ‘Big Freeze’ at the Melbourne Cricket Ground before the Melbourne vs Collingwood AFL clash on the Queen’s Birthday weekend. The event, run by FightMND is designed to raise funds for
Read More
Among the many unknowns to emerge from the pandemic, the working from home phenomenon has plagued executive management but questions as to whether it would become the norm have been categorically answered with a resounding YES. Surveys have shown that working from home improves productivity and contributes to a better work life balance. Not having
Read More
Personalised medicine is quickly becoming the new standard of healthcare thanks to the ease of genetic testing and technological advancements. Genetic Technologies (ASX: GTG) is pioneering a preventative, individualised approach to the COVID-19 pandemic through their experience in genomics and AI driven preventative health. Having already created genetic testing kits to predict breast and colorectal
Read More
Sufferers of asthma and COPD in the United States could soon have access to a digital inhaler device that will alert them when they have not inhaled enough medication as part of their treatment program with medtech company Adherium (ASX: ADR) submitting an FDA application for their device. The application is for their Hallie® product,
Read More
Embattled forensic software and data analytics company Nuix (ASX: NXL) is deep in damage control following media reports of questionable practices, today downgrading their revenue forecasts, citing “uncertainty” in their ability to convert upsell opportunities. The market update revises Nuix’s FY21 pro-forma revenue forecast to $173m-$182m, having previously forecast $180m-$185m in April 2021. Pro-forma EBITDA
Read More
